BCTX

BriaCell Therapeutics Corp. BCTX

BCTX
BriaCell Therapeutics Corp. PCSA
Processa Pharmaceuticals, Inc. CRIS
Curis, Inc. ENTO
Entero Therapeutics, Inc. LPTX
Leap Therapeutics, Inc. PALI
Palisade Bio, Inc. HOTH
Hoth Therapeutics, Inc. ALLR
Allarity Therapeutics, Inc. MBRX
Moleculin Biotech, Inc. ASBP
Aspire Biopharma Holdings, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode BCTX PCSA CRIS ENTO LPTX PALI HOTH ALLR MBRX ASBP
6M -72.39 % -46.58 % -51.61 % 89.21 % 314.45 % 203.16 % -12.61 % 6.06 % -47.01 % -59.52 %
YTD -90.70 % -84.41 % -75.24 % 35.57 % -63.66 % 18.28 % 35.05 % -5.41 % -91.19 % -99.16 %
1Y -89.93 % -85.33 % -66.56 % 39.15 % -60.74 % 24.29 % 36.84 % -2.78 % -91.19 % -99.16 %
3Y -98.74 % -99.40 % -88.83 % -98.74 % -72.98 % -91.85 % -66.12 % -100.00 % -99.06 % -99.16 %
5Y -98.68 % -99.90 % -99.33 % -100.00 % -94.71 % -99.94 % -97.48 % -100.00 % -99.81 % -99.16 %
10Y 5 226.92 % -99.56 % -99.63 % -100.00 % -98.51 % -100.00 % -99.51 % -100.00 % -99.98 % -99.16 %
Depuis le début 1 644.55 % -99.96 % -99.96 % -100.00 % -98.51 % -100.00 % -99.51 % -100.00 % -99.98 % -99.16 %

Dividende